The Recall Desk

Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Filters

Agency

Category

Minimum severity

Clear filters

7401–7425 of 17772

  • ModerateFDA (Drugs)·D-1729-2019·2019-08-21

    US Pharmaceuticals Recalls Adult Glycerin Suppositories Due to Water Quality Issues

    US Pharmaceuticals is recalling 196 cases of Adult Glycerin Suppositories because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.

    Product
    Adult Glycerin Suppositories, Package Size 50-count suppositories, Distributed By: Walgreen Co. 200 Wilmot Rd. Deerfield, IL 60015. NDC#0363-0441-50
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1730-2019·2019-08-21

    US Pharmaceuticals Recalls Adult Glycerin Suppositories for Water Quality Issues

    US Pharmaceuticals is recalling 880 cases of Adult Glycerin Suppositories because purified water used in manufacturing failed quality tests for microbial count or organic carbon.

    Product
    Adult Glycerin Suppositories, Package Size 100-count suppositories, Distributed By: Walgreen Co. 200 Wilmot Rd. Deerfield, IL 60015. NDC#0363-0441-00
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1731-2019·2019-08-21

    US Pharmaceuticals Recalls Hydrocortisone Cream Due to Water Quality Issues

    US Pharmaceuticals is recalling Maximum Strength Hydrocortisone Cream with Aloe due to out-of-specification results in the purified water used during manufacturing.

    Product
    MAXIMUM STRENGTH HYDROCORTISONE CREAM WITH ALOE — MAXIMUM STRENGTH HYDROCORTISONE CREAM WITH ALOE (HYDROCORTISONE CREAM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1720-2019·2019-08-21

    Lupin Recalls Lisinopril and Hydrochlorothiazide Tablets Due to Foreign Substance

    Lupin Pharmaceuticals is recalling specific bottles of Lisinopril and Hydrochlorothiazide tablets due to the presence of brownish or blackish stains and powder.

    Product
    LISINOPRIL AND HYDROCHLOROTHIAZIDE — LISINOPRIL AND HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE)
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-1733-2019·2019-08-21

    US Pharmaceuticals Recalls Hydrocortisone Cream Due to Water Quality Issues

    US Pharmaceuticals Inc. is recalling 305 cases of Maximum Strength Hydrocortisone Cream because the purified water used in manufacturing failed quality tests.

    Product
    MAXIMUM STRENGTH HYDROCORTISONE CREAM — MAXIMUM STRENGTH HYDROCORTISONE CREAM (HYDROCORTISONE CREAM)
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1722-2019·2019-08-21

    Alvogen Recalls Nitrofurantoin Capsules Due to Failed Dissolution Specifications

    Alvogen, Inc. is recalling 2,784 bottles of Nitrofurantoin Monohydrate/Macrocrystalline capsules because they failed to meet dissolution specifications.

    Product
    NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE — NITROFURANTOIN MONOHYDRATE/ MACROCRYSTALLINE (NITROFURANTOIN MONOHYDRATE/MACROCRYSTALLINE)
    Category
    Drug
    Distribution
    0 states
  • ModerateFDA (Drugs)·D-1736-2019·2019-08-21

    CVS Health Glycerin Suppositories Recalled for Water Quality Issues

    US Pharmaceuticals is recalling CVS Health Glycerin Suppositories because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.

    Product
    CVS Health Glycerin Suppositories, 100- count box, Distributed by:Distributed by: CVS Pharmacy, Inc. One CVS Drive Woonsocket, RI 02895. UPC 0 50428 42738 5
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1737-2019·2019-08-21

    US Pharmaceuticals Recalls CRYO-273 Cold Pain Gel Due to Water Quality Issues

    US Pharmaceuticals is recalling CRYO-273 Cold Pain Relieving Gel Roll-On because the purified water used in manufacturing failed quality tests for microbial count or organic carbon.

    Product
    CRYO-273 Cold Pain Relieving Gel Roll-On 3 FL. OZ. (89 mL) Distributed By: CRYO-273.com Tampa, FL 33629. UPC 8 15290 01529 6
    Category
    Drug
    Distribution
    Distributed nationwide
  • ModerateFDA (Drugs)·D-1728-2019·2019-08-21

    US Pharmaceuticals Recalls Walgreens Glycerin Suppositories for Water Quality Issues

    US Pharmaceuticals is recalling 98 cases of Walgreens Adult Glycerin Suppositories due to out-of-specification results in the purified water used during manufacturing.

    Product
    WALGREENS ADULT GLYCERIN — WALGREENS ADULT GLYCERIN (GLYCERIN SUPPOSITORY)
    Category
    Drug
    Distribution
    Distributed nationwide
  • LowFDA (Drugs)·D-1743-2019·2019-08-21

    Glenmark Recalls Clotrimazole and Betamethasone Cream Due to Temperature Abuse

    Glenmark Pharmaceuticals is recalling 31,224 tubes of Clotrimazole and Betamethasone Dipropionate Cream due to complaints of a liquidy texture caused by temperature abuse.

    Product
    CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE — CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE (CLOTRIMAZOLE AND BETAMETHASONE DIPROPIONATE)
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1671-2019·2019-08-14

    RXQ Compounding Recalls Lidocaine Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Lidocaine HCL 1% Injection Solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    LIDOCAINE HCL 1% INJECTION SOLUTION (NPV), 20ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0174-20
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1642-2019·2019-08-14

    RXQ Compounding Recalls Calcium Glucunate Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Calcium Glucunate 5% Injection Solution because the FDA determined there is a lack of assurance of sterility.

    Product
    CALCIUM GLUCONATE 5% INJECTION SOLUTION (MDV), 20 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0903-20
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1646-2019·2019-08-14

    RXQ Compounding Recalls Dextrose 50% Injection Syringes Due to Sterility Concerns

    RXQ Compounding LLC is recalling Dextrose 50% Injection Solution syringes because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    DEXTROSE 50% INJECTION SOLUTION (PF) SYRINGE, 50 ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0969-89
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1644-2019·2019-08-14

    RXQ Compounding Recalls Cyanocobalamin Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Cyanocobalamin 1200mcg/mL MDV Injection due to a lack of assurance of sterility. The product is distributed nationwide.

    Product
    CYANCOBALAMIN 1200MCG/ML MDV INJECTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0946-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1713-2019·2019-08-14

    RXQ Compounding Recalls Ophthalmic Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Turbo Drops ophthalmic solution because the product may not be sterile.

    Product
    TURBO DROPS (PHEN 0.625%/CYCLO 0.25%/TROP 0.25%/KETO 0.125%) OPHTH SOLN, 0.4 ML per Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0192-81
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1647-2019·2019-08-14

    RXQ Compounding Recalls Dextrose 50% Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling Dextrose 50% Injection Solution vials because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    DEXTROSE 50% INJECTION SOLUTION (PF) VIAL, 50 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0969-89
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1634-2019·2019-08-14

    RXQ Compounding Recalls Ascorbic Acid Injection Due to Crystallization

    RXQ Compounding LLC is voluntarily recalling Ascorbic Acid 500 MG/ML Injection due to crystallization. The recall covers all lots within expiry distributed nationwide.

    Product
    Ascorbic Acid 500 MG/ML (Non-Corn) Injection (PFV), 50 mL per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0173-10
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1684-2019·2019-08-14

    RXQ Compounding Recalls Mitomycin Ophthalmic Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Mitomycin 0.04% ophthalmic solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    MITOMYCIN 0.04% (PF) OPH SOLN, 1ML per syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0917-01
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1715-2019·2019-08-14

    RXQ Compounding Recalls Turbo Drops Ophthalmic Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Turbo Drops ophthalmic solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    TURBO DROPS (PHEN 2.5% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0205-05
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1693-2019·2019-08-14

    RXQ Compounding Recalls PHO-TID-CHOL Injection Due to Sterility Concerns

    RXQ Compounding LLC is recalling PHO-TID-CHOL 50MG/DEOXYCHOLIC 42 MG/ML Injection due to a lack of assurance of sterility.

    Product
    PHO-TID-CHOL 50MG/ DEOXYCHOLIC 42 MG/ML INJ, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0953-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1701-2019·2019-08-14

    RXQ Compounding Recalls Riboflavin Ophthalmic Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Riboflavin 0.1% Ophthalmic Solution syringes because the product lacks assurance of sterility.

    Product
    RIBOFLAVIN 0.1% OPHTHALMIC SOLUTION SYRINGE, 2 ML per syringe. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0923-02
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1697-2019·2019-08-14

    RXQ Compounding Recalls Procaine HCL Injectable Solution Due to Sterility Concerns

    RXQ Compounding LLC is recalling Procaine HCL 20 mg/mL Injectable Solution because the product lacks assurance of sterility. The recall covers all lots within expiry distributed nationwide.

    Product
    PROCAINE HCL (PFV) 20 MG/ML INJECTABLE SOLUTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0900-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1681-2019·2019-08-14

    RXQ Compounding Recalls MIC B12 W/B6 Due to Sterility Concerns

    RXQ Compounding LLC is recalling MIC B12 W/B6 (Lipostat Plus) vials because the FDA identified a lack of assurance of sterility.

    Product
    MIC B12 W/B6 (LIPOSTAT PLUS) 25/50/50/1/.175 MG/ML, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0978-30
    Category
    Drug
    Distribution
    Distributed nationwide
  • SevereFDA (Drugs)·D-1654-2019·2019-08-14

    RXQ Compounding Recalls Edetate Disodium Due to Sterility Concerns

    RXQ Compounding LLC is recalling Edetate Disodium 150mg/mL PFV vials because the product lacks assurance of sterility.

    Product
    Edetate Disodium150mg/mL PFV, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0934-11
    Category
    Drug
    Distribution
    Distributed nationwide